sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
cccaucucacuuuaauaauaa | 1938 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaucucacuuuaauaauaa | 1938 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagaaacugggagcaaagauauu | 2223 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagaaacugggagcaaagauauu | 2223 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagaaacugggagcaaagauauu | 3288 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagaaacugggagcaaagauauu | 3288 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 2155 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 2155 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 2961 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 2961 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 1896 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 1896 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 315 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 315 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 3220 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 3220 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 765 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 765 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 45 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 45 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 495 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cacugaagugaauacauggua | 495 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acguauugugaaauuuguuaa | 2987 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acguauugugaaauuuguuaa | 2987 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acguauugugaaauuuguuaa | 1922 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acguauugugaaauuuguuaa | 1922 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cuucccuuaauauuuaucuga | 3089 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cuucccuuaauauuuaucuga | 3089 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cuucccuuaauauuuaucuga | 2024 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cuucccuuaauauuuaucuga | 2024 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gacaugcuagcaguuuauaua | 3027 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gacaugcuagcaguuuauaua | 3027 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gacaugcuagcaguuuauaua | 1962 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gacaugcuagcaguuuauaua | 1962 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uauaagugguagucacuuaggug | 1787 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uauaagugguagucacuuaggug | 1787 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uauaagugguagucacuuaggug | 1530 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uauaagugguagucacuuaggug | 1530 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuucaugaauacauccauggcua | 3562 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuucaugaauacauccauggcua | 3562 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuucaugaauacauccauggcua | 2497 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuucaugaauacauccauggcua | 2497 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gcacauauuagcacauucaaa | 3004 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gcacauauuagcacauucaaa | 3004 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gcacauauuagcacauucaaa | 1939 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gcacauauuagcacauucaaa | 1939 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaaugagugacuauaaggaua | 3040 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaaugagugacuauaaggaua | 3040 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaaugagugacuauaaggaua | 2109 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaaugagugacuauaaggaua | 2109 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaaugagugacuauaaggaua | 1975 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaaugagugacuauaaggaua | 1975 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaaugagugacuauaaggaua | 3174 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaaugagugacuauaaggaua | 3174 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gcucuuccauggcguacaagugc | 1166 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gcucuuccauggcguacaagugc | 1166 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cagacggaagcugugugcc | 960 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gccagcagcauggguggca | 2582 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
ggaggccacugcauuuuga | 3077 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
acacacccguggguggcga | 1650 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
cugugcggguugcagaugc | 2851 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
cagacuccagggcuccagc | 2616 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
ugccaaguguuccagaaau | 2430 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
uggcugacaucauuguggc | 2120 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
acgaggaaaacaagagugc | 285 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gugccccggggagaagagc | 2915 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
aaauauuucuggaacuagu | 1779 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
uaguaaaaacauaguccug | 3339 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
ucuucugcaaagccagucu | 1121 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
agccugagaaauaggacuu | 3152 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
aguaguucaucaucugggg | 373 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gucauucuuuuucucauca | 1440 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gaaugagucgccacccacg | 1635 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
uguuccagaaaugaugucc | 2416 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
aagaagaugagacacugaaucug | 4321 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
ucacagccuggcaucaucu | 1946 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
ugacucaacccucuucacc | 1899 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gugccaucuggacucugcu | 932 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gugucuucugcaaagccag | 1115 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gauguccauuuuuggcaug | 2398 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gaaccggcgagcacacauc | 1523 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
caagggauucgaaacagcc | 2041 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gggauaagaaugggcagcg | 602 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
ucccuccgccucgagcccc | 2326 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
auguuuuuacuauagauua | 3326 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
ccccaaucccuccgccucg | 2338 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
cuguuguccacugccccag | 2795 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
agauuaaaauuuaauauaa | 271 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gcaggugguacuagaaaua | 1751 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
ccccaggccuuucugcaga | 645 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
uuggggcaguuuugggcau | 730 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
uggugaagaugaagccagc | 2532 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
ugagaaauaggacuucucu | 3144 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
ggaucgggauggagucaug | 2369 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gaguaaaucucacagccug | 1962 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
gugucucaucuucuucaag | 1307 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
ugagaaaaagaaugaccac | 1445 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
accuccaugggaaagaugc | 1837 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
guuuccacuuuucaguaug | 1373 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
uggcuuguggcaggcaagg | 1010 | AU2020286311A1 | Compositions and methods for inhibiting expression of the ALAS1 gene | 20,210,121 | 3 | [
"CL",
"ZA",
"MX",
"IL",
"IT",
"HK",
"SK",
"TW",
"TR",
"CA",
"CY",
"MY",
"AU",
"KR",
"AR",
"EE",
"DO",
"US",
"LT",
"IN",
"GC",
"HU",
"JP",
"AT",
"UA",
"EP",
"NZ",
"WO",
"BR",
"PH",
"SG",
"SI",
"EA",
"OA",
"PT",
"HR",
"CN",
"ID",
"NO",
"DK"... | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.